Dark

ABUS
Arbutus Biopharma Corporation Common Stock
stock NASDAQ

At Close

May 22, 2026 3:59:59 PM EDT

4.33USD-2.477%(-0.11)847,357

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 21, 2026 9:28:30 AM EDT

4.35USD-2.027%(-0.09)0

After-hours

May 22, 2026 4:00:30 PM EDT

4.35USD+0.462%(+0.02)327,658

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

855.34M

CEO

Mark Murray

Headquarters

Calgary, Alberta, Canada

Industry

Biotechnology

Last Split

Nov 4, 20101for5reverse

PDLI INFI CNAT XLV

ABUS Stats

Avg. Vol. 10 Day

1,309,228

Avg. Vol. 30 Day

1,717,228

Employees

130

Market Cap

855,338,284

Shares Out.

197,537,710

On/Off Exchange

53%/47%

6 Month Beta

1.44

1 Year Beta

1.42

2 Year Beta

0.91

3 Year Beta

0.91

52 Week Low

3.04

52 Week High

5.10

SMA50

4.36

SMA200

4.33

1 Week

+2.12%

1 Month

+1.88%

3 Month

-1.37%

6 Month

+1.41%

1 Year

+34.47%

2 Year

+32.01%

5 Year

+60.37%

Profile

arbutus biopharma corporation (nasdaq:abus) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis b infection, a disease of the liver caused by hepatitis b virus (hbv). we are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the hbv treatment landscape and cure hepatitis b virus disease. in addition to our hbv assets, we are developing a pipeline of programs that leverage our expertise in rna interference (rnai) therapeutics and our lipid nanoparticle (lnp) technology.

ABUS Stock Summary

Arbutus Biopharma Corporation Common Stock (NASDAQ:ABUS) stock price today is $4.33, and today's volume is 847,357. ABUS is down -2.477% today. The 30 day average volume is 1,717,228. ABUS market cap is 855.34M with 197,537,710 shares outstanding.